• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

WHO, WTO, WIPO Put Their Collective Mind To Antibiotic Resistance Calamity

25/10/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment

Resistance to antibiotics by bacteria has been steadily growing and is now considered as a major threat to global public health, with some catastrophic projections of millions of death and billions of dollars in economic impact. The World Trade Organization, World Health Organization and World Intellectual Property Organization today are holding a joint technical symposium on antimicrobial resistance, and how to encourage innovation, appropriate use of antibiotics, and wide access to treatments and diagnostics.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, English, Health & IP, Innovation/ R&D, Patents/Designs/Trade Secrets, WHO, WIPO, WTO/TRIPS

US High Court Puts Unreasonable Delay On Trial

21/10/2016 by Steven Seidenberg for Intellectual Property Watch Leave a Comment

On its face, the case is a humdrum, procedural dispute about a patentee’s delay in filing an infringement suit. But if the Supreme Court rules the way most experts expect, the decision will significantly enhance the power of patent trolls and others alleging patent infringement, and it will harm many companies doing business in the US – especially companies in the tech sector. Much hangs in the balance on 1 November, when the Supreme Court hears oral arguments in SCA Hygiene Products AG v. First Quality Baby Products, LLC.

Filed Under: Features, IP Policies, Language, Subscribers, Themes, Venues, Copyright Policy, Enforcement, English, IP Law, Innovation/ R&D, North America, Patents/Designs/Trade Secrets, Perspectives on the US, Regional Policy

Indian Company Moves To Provide Affordable Insulin Biosimilar In Europe As Patents Rise

19/10/2016 by Tatum Anderson for Intellectual Property Watch Leave a Comment

Bangalore-based Biocon may become the first Indian company to offer a biosimilar insulin in Europe. And the patent and pricing story is interesting.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Asia/Pacific, English, Europe, Health & IP, Innovation/ R&D, Patents/Designs/Trade Secrets, Regional Policy

WIPO Wants Its Pro Bono Patent Lawyer Scheme To Aid Developing Countries’ Inventors

18/10/2016 by Peter Kenny for Intellectual Property Watch Leave a Comment

Imagine you’re an inventor in the Philippines and want to file a patent for, say, a fishing implement you’ve invented, but your $9,000 a year income thwarts your ability to pay the legal fees to register it and develop it commercially.

You could be stumped from the start.

Filed Under: IP Policies, Language, Themes, Venues, English, Innovation/ R&D, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WIPO

WHO Pandemic Influenza Advisory Group Meeting In Secret This Week

18/10/2016 by Intellectual Property Watch 1 Comment

The World Health Organization pandemic influenza framework advisory group is meeting this week, behind closed doors. A consultation is expected to take place on 20 October with stakeholders, and an information session has been organised on 21 October on the work of the advisory group, but no press is allowed in either meeting nor able to obtain any information about any aspect of the week’s events.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, English, Health & IP, Innovation/ R&D, Patents/Designs/Trade Secrets, WHO

55 Civil Society Groups Ask US Government To Allow Export Of Affordable Version Of Prostate Cancer Drug Xtandi

17/10/2016 by Intellectual Property Watch 1 Comment

A range of 55 civil society organisations from around the world today sent a letter asking the United States Department of Health and Human Services to accept an offer from a Canadian generics company, Biolyse Pharma, to manufacture and export high-priced cancer drug Xtandi to countries with a per capita income of less than one-third that of the United States.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, English, Health & IP, Human Rights, Innovation/ R&D, Lobbying, North America, Patents/Designs/Trade Secrets, Regional Policy

FTC Recommends Legislative Fixes For Nuisance Patent Lawsuits But Some Question Study

17/10/2016 by Dugie Standeford for Intellectual Property Watch 1 Comment

LONDON — Procedural and substantive legislative reforms are needed to keep nuisance patent infringement lawsuits at bay, the United States Federal Trade Commission said in an October report. The question is whether the size of the study on activities of “patent assertion entities” (PAEs) was large enough to prove there’s a problem, say some patent attorneys, including speakers at the 13-14 October London IP Summit.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, English, Europe, Innovation/ R&D, Lobbying, North America, Patents/Designs/Trade Secrets, Regional Policy

EPO Staff Seek WIPO-Style Disciplinary Guidelines As Reports Show High Levels Of Discontent

11/10/2016 by Dugie Standeford for Intellectual Property Watch 2 Comments

With management-staff relations at the European Patent Office still spiralling downward, staff members are pressing the office’s governing council to consider adopting proposed disciplinary and investigation guidelines currently under discussion in the World Intellectual Property Organization.

Filed Under: IP Policies, Language, Themes, Venues, Enforcement, English, Europe, Innovation/ R&D, Patents/Designs/Trade Secrets, Regional Policy

New MedsPaL Database: Enhancing Transparency In The Patent Field

07/10/2016 by Alexandra Nightingale for Intellectual Property Watch 1 Comment

A new database was launched this week to facilitate navigation through the patent field and increase transparency surrounding the patent status of medicines and licences.

Filed Under: IP Policies, Language, Themes, Venues, English, Health & IP, Innovation/ R&D, Patents/Designs/Trade Secrets, WHO, WIPO

“We Are Here Today To Be Optimistic”: Stories And Advice From Women In IP

04/10/2016 by Alexandra Nightingale for Intellectual Property Watch Leave a Comment

Under the banner of “inclusive trade,” last week’s World Trade Organization Public Forum hosted an array of sessions to discuss how a wider range of individuals and businesses can participate in the trading system. One prominent subject of discussion therein is how women can overcome the constraints and obstacles preventing them from accessing and obtaining the benefits of trade, and participate more fully in the field of intellectual property.

Filed Under: IP Policies, Language, Themes, Copyright Policy, English, Innovation/ R&D, Lobbying, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, Trademarks/Geographical Indications/Domains, WTO/TRIPS

  • « Previous Page
  • 1
  • …
  • 44
  • 45
  • 46
  • 47
  • 48
  • …
  • 228
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2026 · Global Policy Reporting